Zacks Investment Research on MSN
Why Stryker (SYK) is a top momentum stock for the long term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...
Stryker (NYSE:SYK) recently experienced a significant cyberattack that disrupted elements of its operations. In response, ...
Stryker (NYSE: SYK), the medical devices powerhouse, has recently launched its Sync Badge—a hands-free, wearable communication device designed to enhance collaboration among healthcare teams. This new ...
Stryker (SYK) has drawn fresh attention after recent price moves, with the stock showing a small gain over the past month but ...
Zacks Investment Research on MSN
Stryker (SYK) earnings expected to grow: Should you buy?
The market expects Stryker (SYK) to deliver a year-over-year increase in earnings on higher revenues when it reports results ...
Investors in Stryker Corp (Symbol: SYK) saw new options become available today, for the September 2025 expiration. One of the key data points that goes into the price an option buyer is willing to pay ...
BTIG analyst Ryan Zimmerman maintained a Buy rating on Stryker today and set a price target of $397.00. Claim 30% Off TipRanks. Unlock hedge fund-level data and powerful investing ...
Stryker stock (NYSE: SYK), a medical devices company, has seen a 15% fall this year, in line with the broader S&P500 index, down 17%. Even if we look at the longer term, SYK stock, with 46% returns ...
Stryker (NYSE:SYK) announced today that it entered into a definitive agreement to acquire Amplitude Vascular Systems (AVS).
Investors in Stryker Corp (Symbol: SYK) saw new options begin trading today, for the September 2026 expiration. One of the key data points that goes into the price an option buyer is willing to pay, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results